CAMRELIZUMAB
UNII 73096E137E

Substance Identification & Data

This profile provides standardized clinical and technical data for Camrelizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 73096E137E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1798286-48-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
73096E137E
CAS Registry Number
1798286-48-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CAMRELIZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C123816
National Cancer Institute reference terminology for clinical and research data.
INN ID
10400
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Camrelizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CAMRELIZUMAB

Common Names & Synonyms

ANTI-PD-1 MONOCLONAL ANTIBODY SHR-1210
CAMRELIZUMAB [INN]
CAMRELIZUMAB [WHO-DD]
CARILIZUMAB
CARRELIZUMAB

Systematic Nomenclature

IMMUNOGLOBULIN G4, ANTI-(CELL SURFACE RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL SHR-1210 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SHR-1210 LIGHT CHAIN, DIMER

Technical Codes

SHR-1210

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus